DE1518994A1 - Verfahren zur Herstellung von neuen Beta,10Alpha-Steroiden - Google Patents

Verfahren zur Herstellung von neuen Beta,10Alpha-Steroiden

Info

Publication number
DE1518994A1
DE1518994A1 DE19651518994 DE1518994A DE1518994A1 DE 1518994 A1 DE1518994 A1 DE 1518994A1 DE 19651518994 DE19651518994 DE 19651518994 DE 1518994 A DE1518994 A DE 1518994A DE 1518994 A1 DE1518994 A1 DE 1518994A1
Authority
DE
Germany
Prior art keywords
androsta
general formula
acetoxy
keto
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19651518994
Other languages
German (de)
English (en)
Inventor
Reerink Engbert Harmen
Schoeler Hendrik Frederi Louis
Pieter Westerhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB291965A external-priority patent/GB1139411A/en
Priority claimed from CH846564A external-priority patent/CH454842A/de
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE1518994A1 publication Critical patent/DE1518994A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19651518994 1965-01-22 1965-06-03 Verfahren zur Herstellung von neuen Beta,10Alpha-Steroiden Pending DE1518994A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB291965A GB1139411A (en) 1965-01-22 1965-01-22 Preparation of 10-‡-methyl steroids
CH846564A CH454842A (de) 1965-05-31 1965-05-31 Verfahren zur Herstellung von neuen 9B,10a-Steroiden

Publications (1)

Publication Number Publication Date
DE1518994A1 true DE1518994A1 (de) 1969-09-25

Family

ID=25703347

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19651518994 Pending DE1518994A1 (de) 1965-01-22 1965-06-03 Verfahren zur Herstellung von neuen Beta,10Alpha-Steroiden
DE19651543274 Pending DE1543274A1 (de) 1965-01-22 1965-06-24 Verfahren zur Herstellung von 4-Keto-4,6-bisdehydro-6-halogen-9beta,10alpha-sterioden

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19651543274 Pending DE1543274A1 (de) 1965-01-22 1965-06-24 Verfahren zur Herstellung von 4-Keto-4,6-bisdehydro-6-halogen-9beta,10alpha-sterioden

Country Status (14)

Country Link
US (2) US3423433A (US07118763-20061010-C00002.png)
AT (1) AT261129B (US07118763-20061010-C00002.png)
BE (2) BE665762A (US07118763-20061010-C00002.png)
BR (1) BR6570589D0 (US07118763-20061010-C00002.png)
CH (1) CH464188A (US07118763-20061010-C00002.png)
DE (2) DE1518994A1 (US07118763-20061010-C00002.png)
DK (2) DK120337B (US07118763-20061010-C00002.png)
ES (1) ES314639A1 (US07118763-20061010-C00002.png)
FI (1) FI41743B (US07118763-20061010-C00002.png)
FR (3) FR4631M (US07118763-20061010-C00002.png)
GB (1) GB1087920A (US07118763-20061010-C00002.png)
IL (2) IL23629A (US07118763-20061010-C00002.png)
NL (2) NL6508179A (US07118763-20061010-C00002.png)
SE (1) SE331277B (US07118763-20061010-C00002.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667121A (US07118763-20061010-C00002.png) * 1964-10-28
IL23629A (en) * 1965-01-22 1969-01-29 Hoffmann La Roche 9beta,10alpha-steroids and process for the manufacture thereof
GB1228801A (US07118763-20061010-C00002.png) * 1967-07-11 1971-04-21
US3937700A (en) * 1970-03-04 1976-02-10 U.S. Philips Corporation Novel 1,2-methylene-17α-acyloxy (or improved hydroxy)-9β, 10α-steroid compounds of the pregnane series, pharmaceutic preparations on the basis of the novel compounds and methods of producing said compounds and preparations
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US20070082876A1 (en) * 2005-09-30 2007-04-12 Solvay Pharmaceuticals Gmbh Novel C18 modified retrosteroids as progesterone receptor modulator compounds
US20070212751A1 (en) * 2006-01-18 2007-09-13 Solvay Pharmaceuticals Gmbh Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL252417A (US07118763-20061010-C00002.png) * 1959-06-08
US3258473A (en) * 1963-10-04 1966-06-28 Syntex Corp 17-dihaloacetate esters of 17alpha-hydroxy-21-desoxypregnane derivatives
IL23629A (en) * 1965-01-22 1969-01-29 Hoffmann La Roche 9beta,10alpha-steroids and process for the manufacture thereof

Also Published As

Publication number Publication date
ES314639A1 (es) 1966-02-16
FI41743B (US07118763-20061010-C00002.png) 1969-10-31
NL6508179A (US07118763-20061010-C00002.png) 1965-12-27
CH464188A (de) 1968-10-31
FR1439514A (fr) 1966-05-20
BE666060A (US07118763-20061010-C00002.png) 1965-12-28
FR1446515A (fr) 1966-07-22
DK123352B (da) 1972-06-12
NL6508148A (US07118763-20061010-C00002.png) 1966-06-27
BR6570589D0 (pt) 1973-08-02
DE1543274A1 (de) 1969-07-24
US3304314A (en) 1967-02-14
IL23629A (en) 1969-01-29
GB1087920A (en) 1967-10-18
US3423433A (en) 1969-01-21
BE665762A (US07118763-20061010-C00002.png) 1965-12-22
DK120337B (da) 1971-05-17
AT261129B (de) 1968-04-10
FR4631M (US07118763-20061010-C00002.png) 1966-11-28
IL23785A (en) 1969-09-25
SE331277B (US07118763-20061010-C00002.png) 1970-12-21

Similar Documents

Publication Publication Date Title
DD227966A5 (de) Verfahren zur herstellung neuer carbonsaeureester
DE1518994A1 (de) Verfahren zur Herstellung von neuen Beta,10Alpha-Steroiden
DE3401680A1 (de) 6(alpha),16ss-dimethylkortikoide
EP0003341B1 (de) 11,17-substituierte Pregnane, ihre Herstellung und Verwendung zur Herstellung von pharmazeutischen Präparaten
DE1920145A1 (de) Neue Steroide und deren Herstellung
DE1593052C3 (de) Verfahren zur Herstellung von 16-Methylen-19-norprogesteron-derivaten
EP0023006B1 (de) Verfahren zur Herstellung von ungesättigten Steroiden
DE2636405C2 (de) Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE1668205C3 (de) 16 alpha-Alkylthio-9beta, lOalpha-Steroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2602891A1 (de) Neue 13-aethinyl-steroide und verfahren zu ihrer herstellung
DE1668658B2 (de) 16alpha-Methylverbindungen der Pregnanreihe sowie Verfahren zu deren Herstellung. Ausscheidung aus: 1418390
DE1643016C3 (de) 1,2alpha-Methylensteroide, Verfahren zu deren Herstellung und diese Steroide enthaltende Mittel
DE1468421C (de) Neu 9beta,10alpha Steroide der Pregnanreihe und Verfahren zu ihrer Herstellung
DE2508136C3 (de) Neue Steroide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
AT270887B (de) Verfahren zur Herstellung von neuen 9β,10α-Steroiden
DE1618511A1 (de) Verfahren zur Herstellung von neuen 9ss 10alpha-Steroiden
DE2441647A1 (de) 17beta-aethinyl-3,17alpha-oestradiolverbindungen, verfahren zu ihrer herstellung, arzneimittel und 17beta-aethinyl-16alpha, 17alpha-epoxyoestran-3-olverbindungen
DE1802962C3 (de) Neue Galpha, 6beta-Dlfluorsteroide, Verfahren zu ihrer Herstellung, sowie diese enthaltende Mittel
DE1443957C (de) 9 alpha-Chlor- bzw. 9 alpha-Fluor-. 16 beta-methyl-prednisolon-17,21-diester und ein Verfahren zu deren Herstellung
DE2533496A1 (de) Neue difluorsteroide und verfahren zu ihrer herstellung
DE1241825B (de) Ver fahren zur Herstellung von 6 Chlor 4 6diLirverbindungen der Pregnan-, Androstan oder Cholestanreihe
EP0078235A2 (de) Dihalogenierte Steroide
DE1618493A1 (de) Verfahren zur Herstellung von halogenierten Steroiden
DE1923746A1 (de) 9beta,10Alpha-Steroide
DE1177147B (de) Verfahren zur Herstellung von 3-Enolaethern von 6-Formyl-3-oxo-?-steroiden